ONO Pharmaceutical Co (ON4) Revenue
ONO Pharmaceutical Co Revenue
ONO Pharmaceutical Co had a revenue of 116.34B in the quarter ending Sep 30, 2026, with 0.16%. This bring the company's revenue in the last twelve months to 491.15B, Decreased 2.63%. In the fiscal year ending Mar 31, 2026, ONO Pharmaceutical Co had annual revenue of 515.78B with 5.94% growth.
- Revenue (ttm)
- 491.15B
- Revenue Growth
- -12.02%
- P/S Ratio
- 0.01
- Revenue/Employee
- EUR 122,630,766
- Employees
- 4,206
- Market Cap
- EUR 6.01B
Revenue Chart
ONO Pharmaceutical Co Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 515.78B | 28.91B | 5.94% |
| Mar 31, 2026 | 486.87B | -15.80B | -3.14% |
| Mar 31, 2025 | 502.67B | 55.48B | 12.41% |
| Mar 31, 2024 | 447.19B | 85.83B | 23.75% |
| Mar 31, 2023 | 361.36B | 52.08B | 16.84% |
| Mar 31, 2022 | 309.28B | 16.86B | 5.77% |
| Mar 31, 2021 | 292.42B | 3.79B | 1.31% |
| Mar 31, 2020 | 288.63B | 26.80B | 10.23% |
| Mar 31, 2019 | 261.84B | 17.04B | 6.96% |
| Mar 31, 2017 | 244.80B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.